文献速递中医内科中医儿科中药与中成药合理使用

半夏白术天麻汤减轻戊四氮致癫痫大鼠发作并调节代谢谱

Banxia Baizhu Tianma Decoction alleviates pentylenetetrazol-induced epileptic seizures in rats by preventing neuronal cell damage and apoptosis and altering serum and urine metabolic profiles.
PubMed 文献 · J Ethnopharmacol · 2024-11-15

该研究用戊四氮诱导癫痫大鼠模型,观察半夏白术天麻汤的抗癫痫作用及机制。结果显示该方降低发作等级、缩短发作时长,减轻运动皮层神经元损伤并抑制凋亡,同时逆转脑内GABA下降与Glu升高;代谢组学提示其作用与维生素B6、嘧啶、嘌呤及甘油磷脂代谢相关。

要点

  • 半夏白术天麻汤可降低戊四氮致癫痫大鼠的发作严重程度并缩短发作持续时间。
  • 该方减轻运动皮层神经元损伤、抑制凋亡,并逆转脑内GABA降低与Glu升高。
  • 血清和尿液代谢组学提示其作用涉及维生素B6、嘧啶、嘌呤及甘油磷脂代谢。

核心结论

  • 半夏白术天麻汤在戊四氮诱导的癫痫大鼠中通过调节神经递质平衡、减少神经元损伤和抑制凋亡发挥抗癫痫作用。
  • 该研究首次采用基于UHPLC-MS的尿液和血清代谢组学阐释半夏白术天麻汤的抗癫痫机制。

研究设计与样本

  • 研究采用戊四氮诱导的癫痫大鼠模型,给予半夏白术天麻汤治疗。
  • 研究记录发作等级和持续时间,采用尼氏染色观察运动皮层病理改变,用蛋白质印迹法检测Bax和Bcl-2表达。
  • 研究检测脑组织GABA和Glu水平,并采用非靶向代谢组学分析血清和尿液代谢物,进行代谢物相关靶点的网络分析。

主要发现

  • 半夏白术天麻汤治疗后,癫痫模型大鼠发作严重程度降低、发作持续时间缩短。
  • 治疗后运动皮层尼氏体数量显著增加,提示神经元损伤减轻。
  • 治疗上调抗凋亡蛋白Bcl-2并下调促凋亡蛋白Bax,提示抑制神经元凋亡。
  • 治疗逆转模型组脑组织GABA水平降低和Glu水平升高。
  • 代谢组学提示治疗作用与尿液维生素B6和嘧啶代谢及血清嘌呤、甘油磷脂和维生素B6代谢改变相关;网络分析提示多巴胺和α-亚麻酸代谢物可能发挥重要作用。

临床怎么用

  • 该研究为半夏白术天麻汤用于癫痫的临床管理提供了动物实验层面的机制支持。
  • 结果提示该方可能通过调节神经递质平衡和代谢途径发挥抗癫痫作用,但尚需临床研究验证。

局限性

  • 研究为戊四氮诱导的大鼠模型,结论外推至儿童癫痫患者需谨慎。
  • 代谢组学结果为关联性提示,多巴胺和α-亚麻酸代谢物的作用仍需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Epilepsy (EP) is one of the most prevalent chronic neurological disorders in children, characterised by a prolonged course and a propensity for recurrence. Banxia Baizhu Tianma Decoction (BBTD), a traditional Chinese medicine formula, is commonly employed in the clinical management of EP and has demonstrated satisfactory therapeutic effects. AIM OF THE STUDY: This study aimed to evaluate the anti-epileptic effects of BBTD and to explore its molecular mechanisms. MATERIALS AND METHODS: EP rat model was induced by pentylenetetrazol (PTZ) and treated with BBTD. Parameters such as seizure grade and duration were recorded to evaluate the improvement of BBTD on epileptic behavior. Nissl staining was used to observe the pathological changes in the cerebral motor cortex. The expression levels of the Bax and Bcl-2 in the motor cortex were measured by western blot analysis to assess neuronal damage and apoptosis. The therapeutic action of BBTD was evaluated by examining the levels of neurotransmitters γ-aminobutyric acid (GABA) and glutamate (Glu) in the brain tissue of EP rats, along with assessments of neuronal damage and apoptosis. Non-targeted metabolomics techniques were employed to conduct a comprehensive analysis of serum and urine metabolites, and network analysis of metabolite-related targets was performed to enhance understanding of the anti-epileptic effects and mechanisms of BBTD. RESULTS: After BBTD treatment, the EP model rats exhibited reduced seizure severity and shortened seizure duration. Moreover, BBTD mitigated PTZ-induced neuronal damage, as evidenced by a significant increase in the number of Nissl bodies in the motor cortex following treatment. At the same time, BBTD inhibited neuronal apoptosis, as demonstrated by the up-regulation of the anti-apoptotic protein Bcl-2 and down-regulation of the pro-apoptotic protein Bax in the brain tissue of treated rats. In addition, BBTD reversed the decreased levels of GABA and the increased levels of Glu in the brain tissue of the model group. Metabolomics analyses suggested that BBTD treatment for EP may be closely associated with alterations in urinary metabolites related to vitamin B6 and pyrimidine metabolism, as well as serum metabolites involved in purine metabolism, glycerophospholipid metabolism and vitamin B6 metabolism. Finally, network analysis of metabolite targets indicated that dopamine and alpha-linolenic acid metabolites may play significant roles in the therapeutic effects of BBTD on EP. CONCLUSION: BBTD demonstrated anti-epileptic effects in PTZ-induced seizure rats by regulating neurotransmitter balance, reducing neuronal damage and inhibiting apoptosis, suggesting its potential for the development of novel AEDs. This is the first time that UHPLC-MS-based urine and serum metabolomics have been used to elucidate the anti-epileptic mechanism of BBTD, providing insights into the underlying mechanisms of BBTD's action.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Gao L, Xie R, Yang X, et al. Banxia Baizhu Tianma Decoction alleviates pentylenetetrazol-induced epileptic seizures in rats by preventing neuronal cell damage and apoptosis and altering serum and urine metabolic profiles. J Ethnopharmacol. 2024. PMID: 39551285. doi:10.1016/j.jep.2024.119112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。